Brady Stephen R Insider Trades

Insider Trading History

Track insider trading activity for Brady Stephen R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tempest Therapeutics
Tempest Therapeutics TPST
President And CEO
Holding Value $699k 550,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.14M 550,000 shares
$11.16
$1.27
Tempest Therapeutics
Tempest Therapeutics TPST
President And CEO
Holding Value $58.9k 46,376 shares
Last Trade
Jul 03, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$73.9k 35,000 shares
$2.11
$1.27
Tempest Therapeutics
Tempest Therapeutics TPST
President And CEO
Holding Value $318k 250,000 shares
Last Trade
Jan 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 250,000 shares
$4.66
$1.27
Tempest Therapeutics
Tempest Therapeutics TPST
President And CEO
Holding Value $921k 725,000 shares
Last Trade
Oct 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.08M 725,000 shares
$9.77
$1.27
Atreca
Atreca BCEL
Director
Holding Value $1.08k 12,000 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.2k 12,000 shares
$1.18
$0.09
Tempest Therapeutics
Tempest Therapeutics TPST
Chief Executive Officer
Holding Value $225k 177,300 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.84M 177,300 shares
$15.99
$1.27
Tempest Therapeutics
Tempest Therapeutics TPST
Chief Executive Officer
Holding Value $220k 173,533 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$408k 173,533 shares
$2.35
$1.27
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Executive Officer
Holding Value $184k 173,533 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 173,533 shares
$1.06
$1.06
Atreca
Atreca BCEL
Director
Holding Value $1.08k 12,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.1k 12,000 shares
$2.09
$0.09
Tempest Therapeutics
Tempest Therapeutics TPST
Chief Executive Officer
Holding Value $120k 94,500 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$515k 94,500 shares
$5.45
$1.27
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Executive Officer
Holding Value $100k 94,500 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 94,500 shares
$1.06
$1.06
Atreca
Atreca BCEL
Director
Holding Value $2.16k 24,000 shares
Last Trade
Jul 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$191k 24,000 shares
$7.95
$0.09
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $2.52M 1,982,250 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.4M 2,162,938 shares
$15.90
$1.27
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Executive Officer
Holding Value $2.1M 1,982,250 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 2,170,988 shares
$1.06
$1.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up